Assessing the Impact of Multiple Sclerosis Symptoms (IMSS) on the quality of life of people with MS to provide personalised care and support
The role of Epstein-Barr virus infection in the pathogenesis of Multiple Sclerosis Background Multiple Sclerosis (MS) is the most frequent…
Targeting Epstein-Barr virus Infection for Treatment and Prevention of Multiple Sclerosis EMSP is joining a ground-breaking EU-funded research with leading…
Well-being improvement through the Integration of healthcare and research Data and models with Out border for chronic iMmune-mediated diseases Summary …
MS Nurse Professional (MS Nurse PRO) is the first and only, online foundation education programme for nurses working in the field of Multiple Sclerosis.
MS is one of the most common neurological disorders and causes of disability in young adults. For that reason, EMSP…
There are significant disparities across Europe in terms of MS care and the national contexts differ widely from one country…
The Multiple Sclerosis Community Advisory Board (MS CAB) is a group of dedicated MS community activists and patient advocate members from different European countries, who have knowledge of scientific as well as policy-related issues.
More-EUROPA focuses on more effective & ethical use of registry data to support patient-centered decisions by drug regulators & HTA agencies.
Rue Auguste Lambiotte 144
1030 Brussels
Belgium
VAT: BE 0473 317 141
ContactThere are several ways to support the European Multiple Sclerosis Platform (EMSP).
Donate Get InvolvedCopyright © EMSP 2024
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.